Tony Lau's Insider Trades & SAST Disclosures
Tony Lau's most recent trade in Niagen Bioscience Inc. was a trade of 20,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 17, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tony Lau.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Niagen Bioscience Inc. | Tony Lau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 | - | - | Stock Options (right to buy) | |
| Celsius Holdings Inc | Tony Lau | Director | Sale of securities on an exchange or to another person at price $ 62.50 per share. | 14 Jun 2021 | 150,000 | 0 (0%) | 0% | 62.5 | 9,375,000 | Common Stock |
| Celsius Holdings Inc | Tony Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 66,666 | 33,334 | - | - | Stock Option (Right to Buy) | |
| Celsius Holdings Inc | Tony Lau | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.60 per share. | 01 Jun 2021 | 61,987 | 99,663 (0%) | 0% | 4.6 | 285,140 | Common Stock |
| Celsius Holdings Inc | Tony Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Celsius Holdings Inc | Tony Lau | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 01 Jun 2021 | 47,345 | 147,008 (0%) | 0% | 3.5 | 164,761 | Common Stock |
| Celsius Holdings Inc | Tony Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 36,666 | 18,334 | - | - | Stock Option (Right to Buy) | |
| Celsius Holdings Inc | Tony Lau | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 01 Jun 2021 | 34,579 | 37,676 (0%) | 0% | 3.7 | 128,980 | Common Stock |
| Celsius Holdings Inc | Tony Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,147 | 51,853 | - | - | Stock Option (Right to Buy) | |
| Celsius Holdings Inc | Tony Lau | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.23 per share. | 01 Jun 2021 | 2,992 | 150,000 (0%) | 0% | 3.2 | 9,664 | Common Stock |
| Niagen Bioscience Inc. | Tony Lau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges